Literature DB >> 13469630

Kojic acid.

A BEELIK.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS

Mesh:

Substances:

Year:  1956        PMID: 13469630

Source DB:  PubMed          Journal:  Adv Carbohydr Chem        ISSN: 0096-5332


× No keyword cloud information.
  6 in total

1.  Kojic acid production by Aspergillus flavus using gelatinized and hydrolyzed sago starch as carbon sources.

Authors:  M Rosfarizan; A B Ariff; M A Hassan; M I Karim
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

Review 2.  Toxins other than aflatoxins produced by Aspergillus flavus.

Authors:  B J Wilson
Journal:  Bacteriol Rev       Date:  1966-06

3.  Metabolic Profiling and In Vitro Assessment of the Biological Activities of the Ethyl Acetate Extract of Penicillium chrysogenum "Endozoic of Cliona sp. Marine Sponge" from the Red Sea (Egypt).

Authors:  Muneera S M Al-Saleem; Wafaa H B Hassan; Zeinab I El Sayed; Mahmoud M Abdel-Aal; Wael M Abdel-Mageed; Eman Abdelsalam; Sahar Abdelaziz
Journal:  Mar Drugs       Date:  2022-05-15       Impact factor: 6.085

Review 4.  Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design.

Authors:  Sahar Tazesh; Elnaz Tamizi; Mohammadreza Siahi Shadbad; Nazli Mostaghimi; Farnaz Monajjemzadeh
Journal:  Adv Pharm Bull       Date:  2021-05-30

5.  Novel kojic acid-polymer-based magnetic nanocomposites for medical applications.

Authors:  Samer Hasan Hussein-Al-Ali; Mohamed Ezzat El Zowalaty; Mohd Zobir Hussein; Maznah Ismail; Dena Dorniani; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2014-01-07

6.  Sonochemistry in an organocatalytic domino reaction: an expedient multicomponent access to structurally functionalized dihydropyrano[3,2-b]pyrans, spiro-pyrano[3,2-b]pyrans, and spiro-indenoquinoxaline-pyranopyrans under ambient conditions.

Authors:  Biplob Borah; Jahnu Bora; Pambala Ramesh; L Raju Chowhan
Journal:  RSC Adv       Date:  2022-04-28       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.